Council Members in this Study Group: 16
This study group may include professors, attorneys, former regulatory officers, and consultants knowledgeable on topics such as law and litigation issues, lobbying, policy and government, elections, antitrust, immigration, intellectual property, and legislation, among others.
Leading institutions connect with members of this Study Group through GLG
Stephen BentPartner
FOLEY & LARDNER LLP ![]()
Stephen A. Bent is Partner and former co-leader of the Life Sciences Industry Team at Foley & Lardner in Washington, DC. He is also a member of the Biotechnology & Pharmaceutical Practice Group and the Health Care and Nanotechnology Industry Teams. Mr. Bent specializes on the legal issues associated...
Principal
Law Offices of Michael D. McNeely ![]()
Michael McNeely is in private practice in Washington, DC, where he provides antitrust counseling and representation. Mr. McNeely consults on the antitrust and antitrust agency aspects of mergers, generic drug approvals, telecommunications, patents, standard setting, and other topics. He also represents...
Of Counsel
STEVENS & LEE P.C. (INC) ![]()
Eugene Lipkowitz is Of Counsel at Stevens & Lee in New York, where he focuses on antitrust, unfair competition, and related subjects. He counsels major institutions and corporations on compliance with federal and state antitrust laws concerning exclusionary behavior, mergers and acquisitions and other...
Mark HoroschakPartner & Chair, Antitrust/Health Law Practices
WOMBLE CARLYLE SANDRIDGE & RICE ![]()
Mark J. Horoschak is a Partner and Practice Group Leader of the Antitrust & Health Law Practice Groups at Womble Carlyle Sandridge & Rice in Charlotte, North Carolina. He has established a broad-based practice, representing both national and regional companies in mergers, joint ventures, and distributional...
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Antitrust: Revolution in the Supreme Court or Chipping Away at the Margins?
March 29, 2007
Antitrust laws take a beating from Supreme Court | www.chron.com
The Supreme Court has chosen to grant review on several antitrust cases in the last couple of years and has generally expressed skepticism at per se approaches in favor of a more nuanced, supposedly fact-based approach. Some of these cases involved quite narrow or specific factual circumstances,...
November 7, 2006
CVS Buying Caremark for About $21.2B | biz.yahoo.com
This merger is likely to attract a thorough antitrust review by the FTC because of that agency's concern with pharmaceutical sales and distribution generally, the magnitude of the transaction, and the fact that it may be a harbinger of future transactions of a similar nature. The antitrust bar...
Treble damages in Rico suits intended as deterrent and to stimulate enforcement
November 7, 2006
Vivendi sues T-Mobile for fraud | www.ft.com
The question has been asked about the reasons behind treble (triple) damages in RICO private lawsuits. The reasons were borrowed from antitrust law although damage calculations and determinations of injury are different.
Antitrust analysis alone would be unlikely to affect this deal but politics might
October 31, 2006
NFU Meets with DOJ on Smithfield Acquisition | www.wisconsinagconnection.com
The DOJ will conduct a thorough review of this proposed merger, as the parties have clearly expected and several influential midwestern Senators have virtually demanded by threatening to hold hearings of their own. At most this appears to be a borderline situation that would be unlikely to lead...
Standards for discounting on bundle of products still unclear
October 6, 2006
Johnson & Johnson Wins Antitrust Suit | dealbook.blogs.nytimes.com
This case involves the concept of bundled discounts which are a common practice in the pharmaceutical industry. An antitrust issue arises when a company gives discounts or rebates based on purchases of a broad line of products which a producer of a single product or limited group of products...